SCHEMBL21342276

SCHEMBL21342276

CCOC(=O)c1cc2c(-c3ccnc(NC)c3)ccn2c(C(C)=O)c1C

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 3/20 0.42
CDK5R1 Q15078 3/20 0.42
JAK3 P52333 1/20 0.38
GSK3B P49841 1/20 0.37
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 3/20 0.36
HPGD P15428 3/20 0.36
GAA P10253 3/20 0.36
GLA P06280 2/20 0.36
EZH2 Q15910 1/20 0.36
AAK1 Q2M2I8 1/20 0.36
PIK3C3 Q8NEB9 3/20 0.35
JMJD6 Q6NYC1 3/20 0.35
NUDT1 P36639 1/20 0.34
MAPT P10636 2/20 0.34
NPC1 O15118 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25514525 0.86 CDK5 (0.38) CDK5CDK5R1JAK3GSK3BALDH1A1
SCHEMBL22817667 0.86 CDK5 (0.39) CDK5CDK5R1JAK3GSK3BALDH1A1
SCHEMBL19964717 0.85 EZH2 (0.39) CDK5CDK5R1ALDH1A1KDM4EHPGD
SCHEMBL21342364 0.85 EZH2 (0.45) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL21342274 0.83 EZH2 (0.39) CDK5CDK5R1JAK3GSK3BEZH2
SCHEMBL19964530 0.80 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL21113045 0.79 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL21156134 0.78 KDM4E (0.47) JAK3ALDH1A1KDM4EHPGDGAA
SCHEMBL19964421 0.77 SMARCA2 (0.51) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL21342091 0.77 EZH2 (0.45) ALDH1A1KDM4EHPGDGAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11661421-B2 Indolizine compounds, preparation method and use thereof HAIHE BIOPHARMA CO., LTD. (CN) 2023-05-30 US disclosed
US-11661421-B2 Indolizine compounds, preparation method and use thereof HAIHE BIOPHARMA CO., LTD. (CN) 2023-05-30 US disclosed
EP-3763712-B1 INDOLIZINE COMPOUNDS, PREPARATION METHOD AND USE THEREOF HAIHE BIOPHARMA CO LTD (CN) 2021-11-24 EP disclosed
EP-3763712-B1 INDOLIZINE COMPOUNDS, PREPARATION METHOD AND USE THEREOF HAIHE BIOPHARMA CO LTD (CN) 2021-11-24 EP disclosed
CN-110229151-B Indolizine compound, preparation method and application thereof 上海海和药物研究开发股份有限公司 2021-09-10 CN disclosed
EP-3763712-A1 INDOLIZINE COMPOUNDS, PREPARATION METHOD AND USE THEREOF Shanghai Haihe Pharmaceutical Co., Ltd. (CN) 2021-01-13 EP disclosed
EP-3763712-A1 INDOLIZINE COMPOUNDS, PREPARATION METHOD AND USE THEREOF Shanghai Haihe Pharmaceutical Co., Ltd. (CN) 2021-01-13 EP disclosed
US-20200399270-A1 INDOLIZINE COMPOUNDS, PREPARATION METHOD AND USE THEREOF HAIHE BIOPHARMA CO., LTD. (CN) 2020-12-24 US disclosed
WO-2019170063-A1 INDOLIZINE COMPOUNDS, PREPARATION METHOD AND USE THEREOF 上海海和药物研究开发有限公司 2019-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11661421-B2 Indolizine compounds, preparation method and use thereof EZH1, EZH2, IKZF3 CDK5 1255/4885CDK5R1 1556/4885JAK3 258/4885
US-20200399270-A1 INDOLIZINE COMPOUNDS, PREPARATION METHOD AND USE THEREOF EZH1, EZH2, IKZF3 CDK5 1255/4885CDK5R1 1556/4885JAK3 258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.